Popular Articles

CardioFocus Receives CE Mark For Atrial Fibrillation Ablation Catheter
CardioFocus, Inc. announced that it has received a CE Mark allowing the company to commence European marketing of the Endoscopic Ablation System (EAS) to treat patients with atrial fibrillation. The EAS is the latest generation, percutaneous catheter system that has been used clinically to treat patients with atrial fibrillation. This novel device incorporates both a micro-endoscope and light energy fibers to give physicians the capacity to actually see within the heart, and for the first time, visually direct the application of energy through a catheter. "We are grateful for the thorough review and the rapid response we received from our notified body," said Burke Barrett, CardioFocus VP of Clinical and Regulatory Affairs.

How Superbugs Control Their Lethal Weapons
It appears that some superbugs have evolved to develop the ability to manipulate the immune system to everyone"s advantage.
News of the day
Immunotherapy Linked To Lower Risk Of Alzheimer's Disease
IVIg treatments, the addition of good antibodies into the blood stream, may hold promise for lowering the risk of Alzheimer"s disease and other similar brain disorders, according to research published in the July 21, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Health Insurance

La. Gov. Jindal Signs Law Expanding Protections For Health Workers Who Refuse Services

Louisiana Gov. Bobby Jindal (R) on Tuesday signed into law a bill (HB 517) that expands health care provider "conscience" protections beyond abortion to also include refusals to provide emergency contraception or participate in certain other procedures, the New Orleans Times-Picayune reports. The law provides job protection and legal immunity to "any person" who refuses to provide abortion services, distribute "abortifacient drugs," work on research involving embryonic stem cells or cloning, or participate in physician-assisted suicide or euthanasia. According to the Times-Picayune, the provision that refers to abortifacient drugs is intended to include EC but not other forms of birth control.Jindal"s administration said the law is necessary to protect the individual rights of doctors, nurses, pharmacists and other health care workers whose personal beliefs might conflict with their professional duties. Opponents of the law, including the Planned Parenthood Federation of America and the American Civil Liberties Union, argue that it will restrict patient access to accurate information and timely services (Barrow/Anderson, New Orleans Times-Picayune, 7/8). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):